Preparation, Characterization and Drug Release of Biodegradable Solid Lipid Nanoparticles

Abstract

Abstract: Biodegradable solid lipid nanoparticles loaded with pueraria flavones(PF-SLN) were prepared by emulsification evaporation-solidification at low temperature with a biodegradable material, stearic acid as the carrier. The morphology and particle size of PF-SLN were measured by TEM and laser light scattering technique, respectively. The physical status of the drug in PF-SLN was analyzed by X-ray powder diffractometry. Its entrapment efficacy in SLN and release were also investigated. PF-SLN is near spherical in shape and the average diameter is (263.82±3.6) nm. Its entrapment effciency (EE) is (67.53±0.12)%. X-ray powder diffraction analysis results show that the pueraria flavones are dispersed with the state of molecular or tiny particles in the matrix of SLN. The results show that the release of PF-SLN occurs rapidly in the early stage and then slowly which accumulate up to 50% in 12 h . The drug release slowly from SLN following matrix erosion. The release profile fits well to the Higuchi equation.

Key words: Biodegradable, Stearic acid, Solid lipid nanoparticle, Pueraria flavone, Material phase analysis

TrendMD:

GUAN Qing-Xiang, ZHU Kun, LIN Tian-Mu, GUAN Qing-Tao, GUO Jie*, YIN Jian-Yuan*. Preparation, Characterization and Drug Release of Biodegradable Solid Lipid Nanoparticles[J]. Chem. J. Chinese Universities, 2010, 31(11): 2298.

References

[1]Müller R. H., Mder K., Gohla S.. Eur. J. Pharm. Biopharm.[J], 2000, 50(1): 161—177 [2]Wissing S. A., Kayser O., Müller R. H.. Adv. Drug Deliv. Rev.[J], 2004, 56(7): 1257—1272 [3]Subedia R. K., Kanga K. W., Choi H. K.. Eur. J. Pharm. Sci.[J], 2009, 37(3/4): 508—513 [4]Casadei M. A., Cerreto F., Cesa S., Giannuzzo M., Feeney M., Marianecci C., Paolicelli P.. Int. J. Pharm.[J], 2006, 325(1/2): 140—146 [5]Müller R. H., Runge S., Ravelli V., Mehnert W., Thünemann A. F., Souto E. B.. Int. J. Pharm.[J], 2006, 317(1): 82—89 [6]Zhang S. H., Shen S. C., Chen Z., Yun J. X., Yao K. J., Chen B. B., Chen J. Z.. Chem. Engin. J.[J], 2008, 144(2): 324—328 [7]Vobalaboina V., Kopparam M.. J. Controlled Release[J], 2004, 95(3): 627—638 [8]Luo Y. F., Chen D. W., Ren L. X., Zhao X. L., Qin J.. J. Controlled Release[J], 2006, 114 (1): 53—59 [9]LIN Wen-Hui(林文慧), ZHU Chun-Yan(朱春燕), CHEN Wei(陈卫), SHI Feng(石峰). China Journal of Chinese Materia Medica(中国中药杂志)[J], 2008, 33(2): 164—168 [10]WANG Lin-Li(王林丽), XIANG Ming-Feng(向明凤). China Pharmaceuticals(中国药业)[J], 2004, 13(8): 78—79 [11]WANG Shu-Jun(王淑君), YAO Chong-Shun(姚崇舜), CHEN Ji-Min(陈济民). Chinese Traditional and Herbal Drugs(中草药)[J], 1996, 27(11): 696—697 [12]YAN Bin(炎彬), SUN Hong(孙虹), HE Xi-Hui(何希辉), ZHAO Yu-Nan(赵玉男), WANG Xue-Li(王雪莉), DU Li-Jun(杜力军). Chin. Pharma. J.(中国药学杂志)[J], 2004, 39(3): 208—211 [13]Bocca C., Caputo O., Cavalli R., Gabriel L., Miglietta A., Gasco M. R.. Int. J. Pharm.[J], 1998, 175(2): 185—193 [14]Cavalli R., Bocca C., Migietta A., Gasco M. R.. STP Pharma. Sci.[J], 1999, 9(2): 183—189 [15]ZHANG Dian-Rui(张典瑞), REN Tian-Chi(任天池), LOU Hong-Xiang(娄红祥), ZHANG Jun-Hua(张君华). Chin. Pharm. J.(中国药学杂志)[J], 2004, 39(2):123—126 [16]Lasic D. D., Ceh B.. Biochim. Biophys. Acta[J], 1995, 1239: 145—156 [17]GAO Xiao-Li(高晓黎), JI Xing-Mei(季兴梅). Chin. Pharm. J.(中国药学杂志)[J], 2003, 38(7): 515—517